{"public_id":"cl_7e0d7e49fba033332de51522b57b39ee","status":"active","superseded_by_public_id":null,"corpus_id":1215691,"text":"Early initiation of therapy is recommended, with azathioprine and rituximab suggested as first-line treatments and methotrexate, mycophenolate mofetil, and mitoxantrone recommended as second-line treatments.","confidence":0.97,"paper":{"corpus_id":1215691,"title":"Update on the diagnosis and treatment of neuromyelitis optica: Recommendations of the Neuromyelitis Optica Study Group (NEMOS)","url":"https://sah.borca.ai/papers/1215691"},"contributors":[{"id":1,"public_id":"12632b8b5f","public_label":"Anonymous (12632b8b5f)","roles":["extraction"],"url":"https://sah.borca.ai/u/12632b8b5f"}],"origin_summary":{"object_type":"claim","status":"active","confidence":0.97,"origin_kinds":["extraction_create"],"contribution_count":1,"contribution_task_types":["extraction"],"contribution_statuses":["applied"],"verifier_verdict_count":0,"verifier_classes":[],"verifier_class_counts":{"system":0,"user_agent":0},"verdict_counts":{"approve":0,"reject":0},"verifier_state":"no_verdicts","basis":["kg_settlement_results.decision_payload.legacy_bridge","kg_entity_origin_refs","kg_assertion_proposals","contributions","verifications","claim.status","claim.confidence"],"limits":["ledger provenance is aggregated; raw contribution and verifier audit rows are not expanded","entity matching uses settlement bridge refs and edge commands"]},"concepts":[{"public_id":"co_261600116dddd708f9f49aaf068661ab","name":"rituximab","description":"A monoclonal antibody used as an immunotherapy for neuromyelitis optica.","types":["drug","biological therapy"],"url":"https://sah.borca.ai/concepts/co_261600116dddd708f9f49aaf068661ab"},{"public_id":"co_accaec3f78adf875713aff2cb24f15f9","name":"second-line treatments","description":"Therapies used when first-line treatment options are not sufficient or appropriate.","types":["treatment category"],"url":"https://sah.borca.ai/concepts/co_accaec3f78adf875713aff2cb24f15f9"},{"public_id":"co_ea84fcf6f4562463961667d7f2494f2f","name":"azathioprine","description":"An immunosuppressive drug suggested as a first-line treatment for neuromyelitis optica.","types":["drug"],"url":"https://sah.borca.ai/concepts/co_ea84fcf6f4562463961667d7f2494f2f"}],"related_claims":[],"url":"https://sah.borca.ai/claims/cl_7e0d7e49fba033332de51522b57b39ee"}